Nebula Research & Development LLC Prothena Corp Public LTD CO Transaction History
Nebula Research & Development LLC
- $1.17 Trillion
- Q2 2025
A detailed history of Nebula Research & Development LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Nebula Research & Development LLC holds 22,857 shares of PRTA stock, worth $226,741. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22,857Holding current value
$226,741% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding PRTA
# of Institutions
219Shares Held
34.2MCall Options Held
879KPut Options Held
791K-
Black Rock Inc. New York, NY3.86MShares$38.3 Million0.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX3.38MShares$33.5 Million3.14% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$22.2 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$21.6 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.27MShares$12.6 Million1.75% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $465M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...